Patent details

EP3833335 Title: PHARMACEUTICAL COMPOSITION COMPRISING HMG-COA REDUCTASE INHIBITORS AND FENOFIBRATE

Basic Information

Publication number:
EP3833335
PCT Application Number:
IB2020057208
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP207641556
PCT Publication Number:
WO2021019493
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL COMPOSITION COMPRISING HMG-COA REDUCTASE INHIBITORS AND FENOFIBRATE
French Title of Invention:
COMPOSITION PHARMACEUTIQUE COMPRENANT DES INHIBITEURS DE RÉDUCTASE HMG-COA ET DU FÉNOFIBRATE
German Title of Invention:
PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT HMG-COA-REDUKTASE-HEMMERN UND FENOFIBRAT
SPC Number:

Dates

Filing date:
30/07/2020
Grant date:
31/08/2022
EP Publication Date:
16/06/2021
PCT Publication Date:
04/02/2021
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/08/2022
EP B1 Publication Date:
31/08/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
30/07/2023
Expiration date:
30/07/2040
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/08/2022
 
 

Name:
Intas Pharmaceuticals Ltd.
Address:
Corporate House, Near Sola Bridge S. G. Highway, Thaltej, Ahmedabad - 380054, Gujarat, India (IN)

Inventor

1

Name:
DHAVALE, Satyavan Shivajirao
Address:
India (IN)

2

Name:
NAIDU, Venkataramana
Address:
India (IN)

3

Name:
PRAJAPATI, Narendra Bhagwatbhai
Address:
India (IN)

4

Name:
RAHANGDALE, Hitendra Netlal
Address:
India (IN)

Priority

1

Priority Number:
201921030870
Priority Date:
31/07/2019
Priority Country:
India (IN)

2

Priority Number:
19201186
Priority Date:
02/10/2019
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61P 3/06; A61K 9/24; A61K 31/505; A61K 31/216; A61K 9/20;

Publication

European Patent Bulletin

1

Issue number:
202235
Publication date:
31/08/2022
Description:
Grant (B1)

2

Issue number:
202516
Publication date:
16/04/2025
Description:
Termination of the opposition

3

Issue number:
202240
Publication date:
05/10/2022
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages